SC
Silverarc Capital Management, LLC disclosed a 7.9% stake in IRLA
Silverarc Capital Management, LLC reported owning 7.9% of IRulya Therapeutics Inc. (IRLA) (880,255 shares) in a Schedule 13G filed Nov 14, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 14, 2026
- Source
- Schedule 13G